| |
|
|
| |
Needle Array Drug Delivery Systems
Devices, Therapeutic Markets, Strategies and Prospects
|
Publication: February 2012
Product Code: NAS858R
|
Evolution in drug delivery device design is changing the way
a growing number of therapeutic substances are administered.
This trend is being fostered by the desire by patients for
more user friendly methods for self-medicating, and by the
need for safer, more reliable drug products that improve
compliance. For drugs designed to be delivered across the
skin, needle arrays are viewed as an approach that addresses
these key healthcare objectives. Needle arrays offer several
advantages when compared to conventional needle technologies
including being minimally invasive due to their small
cross-sectional area, providing precise penetration depth
under the skin, inducing minimal trauma during insertion due
to the advanced tip designs, and increased functionality.
Important needle array fabrication technologies include
micromachining, microforming, LIGA, and structured films.
Prominent needle array form factors include solid (coated
and uncoated) needle arrays, hollow needle arrays,
dissolving needle arrays, programmable needle arrays, and
phase transition needle arrays. |
|
Highlights |
· Provides assessments of
marketed and development stage needle array drug
delivery systems
· Analyzes and evaluates
needle array technology and product research and
development, and assesses the medical market potential
for existing and probable future products
· Provides detailed
descriptions of needle array system business
opportunities, market demographics, and business
strategies
· Provides market data
and forecasts to 2016
· Profiles needle array drug
delivery product and technology
participants, their activities, business
strategies, and corporate alliances and
affiliations
|
|
Summary of Contents |
Executive Summary
Active Transdermal
Delivery Market Dynamics
Drug Classes,
Indications and Demand
The Needle Array Ecosystem
What’s Driving the Growth in Alternative Drug
Delivery?
Competitive Landscape
Risk Factors
Needle Array Architecture, Technology &
Fabrication
Needle Array Design Strategies
Solid Needle Arrays
Hollow Needle Arrays
Coated Needle Arrays
Dissolvable Needle Arrays
Needle Array Geometries &Form Factors
Needle
Array Manufacturing
Material Selection Issues
Fabrication Techniques
Emerging Fabrication
Methods
Needle Array Delivery Systems –
Assessments & Commercial Prospects
Syringe-mounted Arrays
Micronjet
Nanoject
Solid Needle Arrays
sMTS
Macroflux
MicroCor
Micropatch
Nanopatch (ANFF)
OnVax
Unbranded (Nanomed)
Unbranded (U-needle)
Hollow Needle Arrays
hMTS
Micro-Trans
Unbranded (MyLife Technologies)
Dissolvable
Arrays
VaxMAT
Unbranded (BioSerenTach)
Metal Film Needle Arrays
AdminPatch
Phase
Transition Needle Array Patches
Unbranded (BioPharm
Solutions)
Programmable Needle Array Patch
Pyraderm
Unbranded (Janisys)
Spring Powered
Needle Arrays
Unbranded (PKA SoftTouch)
Customizable Needle Arrays
Unbranded (Micropoint
Technologies)
Near-Terms Markets for Needle
Arrays - Assessments & Forecasts
Dermatology/Cosmetic Surgery
Diabetes
Genetic/DNA/Nucleotide Therapeutics
Oncology
Osteoporosis
Reproductive Medicine
Vaccines
Market Factors
Regulatory Considerations
Patient Preferences and Compliance
Managed Care
Initiatives
Company Profiles
|
|
|
|
|
